Frontiers of care

Senator Elena Murelli, first signatory of the amendment to the last budget law extending the use of this precision oncology tool, speaks

Metastatic breast cancer: 'Time to make liquid biopsy available'

The appeal of clinicians and associations: only half of the patients manage to access the test for ESR1 mutations

Metastatic breast cancer: release 15 million for liquid biopsy

Aifa green light for a drug indicated alone in advanced stages for oesophagus and lung and together with chemo for gastric and oesophageal malignancies

Tumours, immunotherapy advances: cures for oesophagus and stomach, plus lung

Thanks to modern diagnostic techniques, the disease can be profiled and thus an 'ad personam' treatment can be set up, with important advantages not only for the individual but also for healthcare

Thanks to modern diagnostic techniques, the disease can be profiled and thus an 'ad personam' treatment can be set up, with important advantages not only for the person but also for health care

Cancer, 'tailor-made' therapy is a reality: customised drugs for over 50,000 patients in Italia

Il carcinoma ovarico è considerato ancora oggi uno dei “big killers” tra le neoplasie ginecologiche, con una sopravvivenza a 5 anni del 43%

Ovarian cancer is still considered one of the 'big killers' among gynaecological malignancies, with a 5-year survival rate of 43%

A national mobilisation unites associations, clinicians and institutions to improve information, prevention and access to innovative treatments against ovarian cancer.

Insieme di Insiemi: the new Italian campaign to inform and support women with ovarian cancer

The Medicines Agency has established the conditions for the reimbursability of the parent of Parp inhibitors indicated in patients with metastatic pancreatic adenocarcinoma who have had no disease progression after at least 16 weeks of a first line of platinum-based chemo

Pancreatic cancer, Aifa approves olaparib With target therapy -47% risk of progression

Aifa has given the go-ahead for the reimbursability of CAR-T therapy in patients refractory to first-line chemo-immunotherapy or relapsed within 12 months after completion of first-line chemo-immunotherapy. The treatment is indicated in specific cases

Non-Hodgkin's lymphomas, earlier CAR-T for those who do not respond to treatment in large B-cell forms

Out of approximately 56,000 new cases a year, almost one in ten affects young people under 40. Thanks to targeted therapies, fertility can increasingly be preserved and the desire for motherhood fulfilled

Breast cancer in under 40s, pregnancy after treatment is possible: here's the latest from science

For the Aiom Foundation, the association of oncology physicians, these examinations should soon be included in the new Essential Levels of Care

Breast and ovarian cancer: one in ten is hereditary. Here's why genetic testing is important

President Carrafiello: 'Results comparable to traditional surgery in particular in cancers of the liver, lung, pancreas and kidney'

Interventional radiology: mini-invasiveness and innovation for the fourth pillar of oncology

An estimated 390,000 new diagnoses will be made in 2025, with a downward trend in men, while the mortality rate is below the EU average, thanks in part to the 'protective factor' of public health. South catching up on free tests but hope trips three times higher than in the Centre-North

Aiom 2025 report: cancer mortality down 9% in Italy, but prevention and inequalities remain crucial challenges

The National Association of Breast Operated Women and the more than 18,500 Federfarma member pharmacies jointly promote the national screening campaign

Breast cancer: one in eight women at risk, but only one in two does mammography screening

The first study in the world to demonstrate the equal efficacy of surgery and high-dose radiotherapy in this rare bone tumour is Italian. The key role of Pavia's CNAO

To treat chordoma of the sacrum adrotherapy as effective as a scalpel but with fewer effects

According to a survey by the AIOM Foundation, only one in ten patients with endocrine-responsive and HER-2-negative metastatic cancer in Italy would perform the test

Liquid biopsy, how much women with advanced breast cancer need it and why there is room for improvement

Green light from Aifa for the reimbursability of a new drug. Compared to hormone treatment alone, in combination it reduces the risk of disease progression or death

Breast cancer, new 'tailor-made' therapy for advanced forms arrives

Aifa approved the extension of the reimbursability of the therapy that acts on ineffective marrow erythropoiesis, i.e. the lack of or insufficient production of red blood cells

Myelodysplasias, green light for therapy that can make six out of ten patients independent of transfusions

In Italy, there are more than 14,000 cases per year and approximately 5,000 deaths. The results of the NO-CUT clinical study change and improve clinical practice

Rectal cancer: 25% of patients can be cured without surgery

Regular exercise can reduce the risk of developing cancer by up to 20%. And have better results from treatment. the call: more attention needs to be paid to independent clinical studies

Cancer, physical activity becomes prevention and treatment at no cost

Obstacles in taking care, costs for transport from home to the hospital and extra visits, for drugs and supplements: the picture of financial toxicity taken for Italy by Aiom researchers

Tumours, 1,800 euro a year from patients for treatment and 16% of women leave their jobs

Laboratory medicine professionals and clinicians together to design virtuous pathways and foster the sustainability of the health service

Tumours and diseases of the nervous system: how the laboratory discovers them before they appear

Each person gets what he or she needs. From bone diseases to Breast Units, increasingly important tailor-made responses according to need

Starting with needs, the invisible red thread linking rare bone diseases with breast cancer

Thanks to biomarkers, treatments with targeted drugs are being expanded, even in the rarest forms. But it is the overall management of the patient that counts, with attention to the psyche and rehabilitation

Brain gliomas, what they are and how to tackle them with precision oncology

Study shows the value of treatment, not yet authorised in Italy, for patients with metastatic hormone-sensitive malignant prostate cancer

Advanced prostate cancer, paving the way for future therapy with radioligand

From conjugated antibodies, first line in triple-negative breast cancer, to combinations with immunotherapy. From Esmo, clinical trials point the way to science

Tumours, increasingly effective treatments thanks to 'combo' therapies: novelties for breast, stomach and bladder

Latest study results from Esmo, the Congress of the European Society for Medical Oncology

Increasingly precise therapies for breast cancer that reduce mortality and recurrence: the latest news

Prevention and screening, together with increasingly effective treatments, are changing the game. But high standards must be maintained

Cancers, fewer people die in Italy than in Europe: drastic drops for lungs and stomach

Officina #Metastable continues its journey with new initiatives dedicated to the co-design and implementation of care pathways on the ground

Breast cancer, 70% of women fear getting worse: 'Need psycho-oncology and close care'

Medicine that puts the whole person at its centre: thus the Rome Trial represents the first prospective demonstration of the superior efficacy of personalised therapies in the management of patients with advanced solid tumours

Tumours, 'made in Italy' study in Nature Medicine certifies precision oncology

Nutritional deficits worsen prognosis and impact treatment. Here comes 'OncoCook', a web series of recipes

Stomach cancer, 50% of sufferers are malnourished: who is at risk and what to do

Europa Donna Italia's requests to institutions ahead of the fifth National Awareness Day on metastatic breast cancer on 13 October

In Italy 52,000 patients live with metastic breast cancer: 'Now cures for all'

Training and raising awareness among inmates and prison staff on correct lifestyles and adherence to screening: agreement between Aiom, Aiom Foundation, Pascale Institute of Naples and the Campania Penitentiary Administration Board

Cancer, in Campania cancer prevention also arrives in prisons

90 per cent of the clinicians surveyed by Aiom ask for clear rules on patient management and 32 per cent state that they are not sufficiently prepared to assist the cancer patient in the final stages also due to the absence of widespread palliative care

Tumori